Vaccines are one of global health’s success stories. Over the last two centuries, they’ve helped us to eradicate smallpox and reduce the burden of diseases like polio. In the last few years, we’ve turned our attention to fighting diseases such as Dengue, Zika, Ebola, SARs and MERs. Today, COVID-19 is at the top of the list, and we need to find an efficacious, safe vaccine as soon as possible.
One of the key challenges of vaccine development is determining whether the immune system correlates to the required level of vaccine protection needed. Assessing the efficacy and safety of vaccines are critical, particularly when given to healthy patients. This requires appropriate preclinical models, testing methodologies, and immunology tools.
Join this one-hour presentation to understand the regulatory guidelines, study designs, and endpoints you need to consider for efficient, effective vaccine development from discovery through nonclinical toxicology safety.
Have a scheduling conflict? Sign up even if you can’t make it; the recording will be shared after.
Rhiannon Jenkinson, PhD
Director of Science, Discovery Services
Sarah Gould, PhD
Senior Principal Scientific Advisor